SCHEMBL14966404

SCHEMBL14966404

Cc1cc(C)c(CNC(=O)c2ccc(CCOc3ccccc3)nn2)c(O)n1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 12/20 0.41
RAB9A P51151 1/20 0.40
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CNR1 P21554 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
OPRM1 P35372 1/20 0.36
OPRK1 P41145 1/20 0.36
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14966545 0.85 KLKB1 (0.41) KLKB1RAB9AHTTSMN1; SMN2KDM4E
SCHEMBL14966659 0.82 LMNA (0.48) KLKB1RAB9ASMN1; SMN2HPGDHSD17B10
SCHEMBL14967198 0.82 SLC6A5 (0.44) KLKB1RAB9AHTTSMN1; SMN2ALDH1A1
SCHEMBL14966827 0.80 SMN1; SMN2 (0.43) KLKB1RAB9AHTTSMN1; SMN2KDM4E
SCHEMBL14966442 0.80 KLKB1 (0.41) KLKB1RAB9AHTTSMN1; SMN2ALDH1A1
SCHEMBL14967341 0.80 MEN1 (0.40) KLKB1RAB9AHTTSMN1; SMN2CNR1
SCHEMBL14966965 0.79 NPC1 (0.47) KLKB1RAB9ASMN1; SMN2HPGDHSD17B10
SCHEMBL14966630 0.79 KLKB1 (0.41) KLKB1SMN1; SMN2KDM4EALDH1A1HPGD
SCHEMBL14966509 0.79 KLKB1 (0.50) KLKB1ALDH1A1HPGDOPRM1OPRK1
SCHEMBL14967152 0.78 KDM4E (0.43) KLKB1RAB9AHTTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2780014-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2014-09-24 EP disclosed
WO-2013075083-A1 MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF CONSTELLATION PHARMACEUTICALS (US) 2013-05-23 WO disclosed